Variant report

Variant	nsv511233
Chromosome Location	chr3:47484797-47494157
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:47484405-47485577	HepG2	liver:	n/a	n/a
2	BCL3	chr3:47485006-47485497	A549	lung:	n/a	n/a
3	BCL3	chr3:47484786-47485633	A549	lung:	n/a	n/a
4	BHLHE40	chr3:47484473-47485547	HepG2	liver:	n/a	n/a
5	BRCA1	chr3:47484711-47485105	HepG2	liver:	n/a	n/a
6	CEBPB	chr3:47484560-47485030	MCF-7	breast:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
7	CEBPB	chr3:47484654-47485042	ECC-1	luminal epithelium:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
8	CEBPB	chr3:47484609-47485012	ECC-1	luminal epithelium:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
9	CEBPB	chr3:47484597-47485119	A549	lung:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
10	CEBPB	chr3:47484594-47485046	MCF-7	breast:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
11	CEBPB	chr3:47484712-47484961	HepG2	liver:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
12	CEBPB	chr3:47484649-47485174	IMR90	lung:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
13	CEBPB	chr3:47484661-47485025	A549	lung:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
14	CEBPB	chr3:47484704-47484938	K562	blood:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
15	CEBPB	chr3:47484642-47485433	HepG2	liver:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
16	CEBPB	chr3:47484632-47485023	Hela-S3	cervix:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
17	CEBPB	chr3:47484694-47485034	A549	lung:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
18	CEBPB	chr3:47484551-47485002	HepG2	liver:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
19	CEBPB	chr3:47484648-47485025	HepG2	liver:	n/a	chr3:47484828-47484839 chr3:47484829-47484840
20	CEBPD	chr3:47484661-47485013	HepG2	liver:	n/a	chr3:47484828-47484839
21	CHD2	chr3:47485202-47485435	HepG2	liver:	n/a	n/a
22	CHD2	chr3:47484520-47484994	HepG2	liver:	n/a	n/a
23	CTCF	chr3:47486431-47486468	GM20000	blood:	n/a	n/a
24	CTCF	chr3:47484714-47484805	ProgFib	skin:	n/a	n/a
25	E2F4	chr3:47484794-47485031	MCF10A-Er-Src	breast:	n/a	n/a
26	EGR1	chr3:47488799-47489070	K562	blood:	n/a	n/a
27	EGR1	chr3:47488813-47489089	K562	blood:	n/a	n/a
28	EP300	chr3:47484540-47485494	HepG2	liver:	n/a	chr3:47484638-47484654
29	EP300	chr3:47484641-47485405	HepG2	liver:	n/a	n/a
30	EP300	chr3:47484576-47485589	HepG2	liver:	n/a	chr3:47485513-47485527 chr3:47484638-47484654
31	ESR1	chr3:47485146-47485540	T-47D	breast:	n/a	chr3:47485325-47485342
32	ESR1	chr3:47485200-47485543	T-47D	breast:	n/a	chr3:47485325-47485342
33	ESR1	chr3:47485159-47485558	T-47D	breast:	n/a	chr3:47485325-47485342
34	ESR1	chr3:47485132-47485534	T-47D	breast:	n/a	chr3:47485325-47485342
35	FOS	chr3:47484674-47485917	MCF10A-Er-Src	breast:	n/a	chr3:47485321-47485332
36	FOS	chr3:47484627-47485951	MCF10A-Er-Src	breast:	n/a	chr3:47485321-47485332
37	FOS	chr3:47484638-47485957	MCF10A-Er-Src	breast:	n/a	chr3:47485321-47485332
38	FOS	chr3:47485717-47485901	MCF10A-Er-Src	breast:	n/a	n/a
39	FOS	chr3:47484659-47485457	MCF10A-Er-Src	breast:	n/a	chr3:47485321-47485332
40	FOSL2	chr3:47484573-47485529	HepG2	liver:	n/a	chr3:47485321-47485332
41	FOSL2	chr3:47484771-47485526	HepG2	liver:	n/a	chr3:47485321-47485332
42	FOSL2	chr3:47484801-47485564	A549	lung:	n/a	chr3:47485321-47485332
43	FOXA1	chr3:47484484-47485547	HepG2	liver:	n/a	n/a
44	FOXA1	chr3:47484461-47485579	HepG2	liver:	n/a	n/a
45	FOXA1	chr3:47484503-47485558	HepG2	liver:	n/a	n/a
46	FOXA1	chr3:47484629-47484889	T-47D	breast:	n/a	n/a
47	FOXA1	chr3:47485186-47485603	HepG2	liver:	n/a	n/a
48	FOXA1	chr3:47485249-47485528	T-47D	breast:	n/a	n/a
49	FOXA1	chr3:47484557-47485136	HepG2	liver:	n/a	n/a
50	FOXA2	chr3:47485052-47485609	A549	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:47485244-47485294	SK-N-MC	brain:	n/a
2	chr3:47485244-47485294	GM12878	blood:	n/a
3	chr3:47485244-47485294	MCF-7	breast:	n/a
4	chr3:47485244-47485294	SAEC	small airway:	n/a
5	chr3:47485244-47485294	U87	brain:	n/a
6	chr3:47485244-47485294	A549	lung:	n/a
7	chr3:47485244-47485294	HCPEpiC	choroid plexus:	n/a
8	chr3:47485244-47485294	AoSMC	blood vessel:	n/a
9	chr3:47485244-47485294	LNCaP	prostate:	n/a
10	chr3:47485244-47485294	HMEC	breast:	n/a
11	chr3:47485244-47485294	Jurkat	blood:	n/a
12	chr3:47485244-47485294	PANC-1	pancreas:	n/a
13	chr3:47485244-47485294	SKMC	muscle:	n/a
14	chr3:47485244-47485294	HEK293	kidney:	embryo
15	chr3:47485244-47485294	NHDF-neo	bronchial:	n/a
16	chr3:47485244-47485294	AG09319	gingival:	n/a
17	chr3:47485244-47485294	T-47D	breast:	n/a
18	chr3:47485244-47485294	Hepatocyte	liver:	n/a
19	chr3:47485244-47485294	GM12891	blood:	n/a
20	chr3:47485244-47485294	AG10803	skin:	n/a
21	chr3:47485244-47485294	HCF	heart:	n/a
22	chr3:47485244-47485294	HRPEpiC	eye:	n/a
23	chr3:47485244-47485294	GM06990	blood:	n/a
24	chr3:47485244-47485294	HAEpiC	amniotic membrane:	n/a
25	chr3:47485244-47485294	AG04449	skin:	fetal
26	chr3:47485244-47485294	HCM	heart:	n/a
27	chr3:47485244-47485294	HepG2	liver:	n/a
28	chr3:47485244-47485294	BJ	skin:	n/a
29	chr3:47485244-47485294	RPTEC	kidney:	n/a
30	chr3:47485244-47485294	ProgFib	skin:	n/a
31	chr3:47485244-47485294	HCT-116	colon:	n/a
32	chr3:47485244-47485294	HEEpiC	esophagus:	n/a
33	chr3:47485244-47485294	PrEC	prostate:	n/a
34	chr3:47485244-47485294	GM12892	blood:	n/a
35	chr3:47485244-47485294	SK-N-SH_RA	brain:	n/a
36	chr3:47485244-47485294	HL-60	blood:	n/a
37	chr3:47485244-47485294	NHBE	bronchial:	n/a
38	chr3:47485244-47485294	IMR90	lung:	fetal
39	chr3:47485244-47485294	PFSK-1	brain:	n/a
40	chr3:47485244-47485294	AG09309	skin:	n/a
41	chr3:47485244-47485294	MCF10A-Er-Src	breast:	n/a
42	chr3:47485244-47485294	Caco-2	colon:	n/a
43	chr3:47485244-47485294	AG04450	lung:	fetal
44	chr3:47485244-47485294	SK-N-SH	brain:	n/a
45	chr3:47485244-47485294	H1-hESC	embryonic stem cell:	embryo
46	chr3:47485244-47485294	HIPEpiC	eye:	n/a
47	chr3:47485244-47485294	GM19239	blood:	n/a
48	chr3:47485244-47485294	K562	blood:	n/a
49	chr3:47485244-47485294	NB4	blood:	n/a
50	chr3:47485244-47485294	NH-A	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:47490125..47492275-chr3:47492500..47495080,2	K562	blood:
2	chr3:47479631..47481186-chr3:47484843..47486561,2	MCF-7	breast:
3	chr3:47490214..47492275-chr3:47492500..47494353,2	K562	blood:
4	chr3:47490125..47492275-chr3:47492500..47495080,2	K562	blood:
5	chr3:47490582..47492929-chr3:47496391..47498138,2	MCF-7	breast:
6	chr3:47490214..47492275-chr3:47492500..47494353,2	K562	blood:
7	chr3:47484894..47485414-chr3:47514547..47515158,2	MCF-7	breast:
8	chr3:47462331..47463040-chr3:47485115..47485755,2	MCF-7	breast:

Variant related genes	Relation type
SCAP	TF binding region
SCAP	CpG island
ENSG00000114650	chromatin interactions

Extended variants
information (count: 291 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:291 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs67862138	chr3:47484797-47484798	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs538530597	chr3:47484806-47484807	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs553679652	chr3:47484822-47484823	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs542397949	chr3:47484886-47484887	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs565537329	chr3:47484887-47484888	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs146871250	chr3:47484909-47484910	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs528385584	chr3:47484946-47484947	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs77852723	chr3:47484952-47484953	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs4858894	chr3:47484953-47484954	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs372087332	chr3:47484954-47484955	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs13101111	chr3:47485021-47485022	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs17080872	chr3:47485029-47485030	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs28653422	chr3:47485064-47485065	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs187624780	chr3:47485076-47485077	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs541741545	chr3:47485077-47485078	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs376146625	chr3:47485101-47485102	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs13058785	chr3:47485121-47485122	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs145760364	chr3:47485189-47485190	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs530278569	chr3:47485244-47485245	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs542414666	chr3:47485255-47485256	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs532008052	chr3:47485297-47485298	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs77843826	chr3:47485358-47485359	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs544876912	chr3:47485380-47485381	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs191549295	chr3:47485392-47485393	Enhancers Weak transcription Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs570492461	chr3:47485434-47485435	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs528514121	chr3:47485447-47485448	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs547247172	chr3:47485462-47485463	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs148094871	chr3:47485512-47485513	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs550688525	chr3:47485513-47485514	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs376295408	chr3:47485522-47485523	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs565639074	chr3:47485579-47485580	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs181712898	chr3:47485646-47485647	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs185882890	chr3:47485647-47485648	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs569784862	chr3:47485711-47485712	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs562426423	chr3:47485745-47485746	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs537127810	chr3:47485746-47485747	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs189948290	chr3:47485815-47485816	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs137941299	chr3:47485829-47485830	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs576897449	chr3:47485892-47485893	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs564671586	chr3:47485908-47485909	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs553658008	chr3:47485933-47485934	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs570682265	chr3:47485935-47485936	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs575099655	chr3:47485939-47485940	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs542024204	chr3:47485940-47485941	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs563894122	chr3:47485973-47485974	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs575779776	chr3:47486017-47486018	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs545891614	chr3:47486117-47486118	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs564282970	chr3:47486125-47486126	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs528420584	chr3:47486240-47486241	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs546609012	chr3:47486261-47486262	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Kartagener syndrome	16639409	CNVD
Biliary cancer	19435499	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute myeloid leukemia	17268525	CNVD
Salivary gland tumor	18059337	CNVD
Gastric cancer	16891809	CNVD
Night blindness	17160897	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Lung cancer	17297452	CNVD
Multiple myeloma	16616336	CNVD
Effusion lymphoma	18079361	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Urothelial cell carcinoma	18451213	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Adrenocortical carcinoma	18281524	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:268 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:47450400-47484800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr3:47463000-47485200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
3	chr3:47463600-47484800	Strong transcription	Primary T cells from cord blood	blood
4	chr3:47471800-47485000	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr3:47472400-47485200	Weak transcription	Fetal Brain Male	brain
6	chr3:47473200-47487200	Weak transcription	HUVEC	blood vessel
7	chr3:47474600-47489600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr3:47476000-47485800	Weak transcription	Fetal Kidney	kidney
9	chr3:47476600-47485400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
10	chr3:47476600-47514200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
11	chr3:47476800-47484800	Weak transcription	NH-A	brain
12	chr3:47478200-47485000	Strong transcription	Dnd41	blood
13	chr3:47478400-47484800	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr3:47479400-47484800	Strong transcription	Primary T helper cells fromperipheralblood	blood
15	chr3:47479600-47485800	Weak transcription	H9 Cell Line	embryonic stem cell
16	chr3:47480400-47485200	Strong transcription	K562	blood
17	chr3:47480800-47484800	Strong transcription	Thymus	Thymus
18	chr3:47481000-47485000	Strong transcription	Primary T regulatory cells fromperipheralblood	blood
19	chr3:47481400-47496000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr3:47481400-47500600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr3:47481600-47486000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr3:47481800-47485000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
23	chr3:47481800-47492600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
24	chr3:47482200-47488800	Weak transcription	Cortex derived primary cultured neurospheres	brain
25	chr3:47482600-47486400	Enhancers	Stomach Mucosa	stomach
26	chr3:47482800-47485000	Strong transcription	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr3:47483000-47486000	Enhancers	Fetal Intestine Large	intestine
28	chr3:47483000-47486400	Enhancers	Fetal Intestine Small	intestine
29	chr3:47483200-47487400	Enhancers	Liver	Liver
30	chr3:47483400-47486000	Enhancers	Pancreas	Pancrea
31	chr3:47483400-47486600	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr3:47483600-47484800	Enhancers	A549	lung
33	chr3:47483600-47485200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
34	chr3:47483600-47485800	Enhancers	Fetal Heart	heart
35	chr3:47483600-47486000	Enhancers	Sigmoid Colon	Sigmoid Colon
36	chr3:47483800-47485000	Enhancers	Colon Smooth Muscle	Colon
37	chr3:47483800-47485200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
38	chr3:47483800-47485400	Enhancers	Ovary	ovary
39	chr3:47483800-47485600	Enhancers	Esophagus	oesophagus
40	chr3:47483800-47486000	Enhancers	Psoas Muscle	Psoas
41	chr3:47483800-47486000	Enhancers	Right Ventricle	heart
42	chr3:47484000-47485000	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr3:47484000-47485000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr3:47484000-47485200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr3:47484000-47486200	Enhancers	Brain Hippocampus Middle	brain
46	chr3:47484000-47507800	Weak transcription	Primary B cells from cord blood	blood
47	chr3:47484000-47511200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr3:47484200-47484800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
49	chr3:47484200-47484800	Flanking Active TSS	Stomach Smooth Muscle	stomach
50	chr3:47484200-47484800	Enhancers	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links